title: Effect of insulin and plasma amino acid concentrations on leucine metabolism in man. Role of substrate availability on estimates of whole body protein synthesis.
abstract: We examined the effect of insulin and plasma amino acid concentrations on leucine kinetics in 15 healthy volunteers (age 22 +/- 2 yr) using the euglycemic insulin clamp technique and an infusion of [1-14C]leucine. Four different experimental conditions were examined: (a) study one, high insulin with reduced plasma amino acid concentrations; (b) study two, high insulin with maintenance of basal plasma amino acid concentrations; (c) study three, high insulin with elevated plasma amino acid concentrations; and (d) study four, basal insulin with elevated plasma amino acid concentrations. Data were analyzed using both the plasma leucine and alpha-ketoisocaproate (the alpha-ketoacid of leucine) specific activities. In study one total leucine flux, leucine oxidation, and nonoxidative leucine disposal (an index of whole body protein synthesis) all decreased (P less than 0.01) regardless of the isotope model utilized. In study two leucine flux did not change, while leucine oxidation increased (P less than 0.01) and nonoxidative leucine disposal was maintained at the basal rate; endogenous leucine flux (an index of whole body protein degradation) decreased (P less than 0.01). In study three total leucine flux, leucine oxidation, and nonoxidative leucine disposal all increased significantly (P less than 0.01). In study four total leucine flux, leucine oxidation, and nonoxidative leucine disposal all increased (P less than 0.001), while endogenous leucine flux decreased (P less than 0.001). We conclude that: (a) hyperinsulinemia alone decreases plasma leucine concentration and inhibits endogenous leucine flux (protein breakdown), leucine oxidation, and nonoxidative leucine disposal (protein synthesis); (b) hyperaminoacidemia, whether in combination with hyperinsulinemia or with maintained basal insulin levels decreases endogenous leucine flux and stimulates both leucine oxidation and nonoxidative leucine disposal.
authors.affiliation: Division of Endocrinology/Diabetes, Yale University School of Medicine, New Haven, Connecticut 06510.
authors.forename: P
authors.initials: P
authors.lastname: Castellino
authors.forename: L
authors.initials: L
authors.lastname: Luzi
authors.forename: D C
authors.initials: DC
authors.lastname: Simonson
authors.forename: M
authors.initials: M
authors.lastname: Haymond
authors.forename: R A
authors.initials: RA
authors.lastname: DeFronzo
mesh_terms: D000328:Adult; D000596:Amino Acids / Q000097:blood*; D005260:Female; D006801:Humans; D007328:Insulin / Q000494:pharmacology*; D007651:Keto Acids / Q000097:blood; D007930:Leucine / Q000378:metabolism*; D008297:Male; D014176:Protein Biosynthesis
chemical_list: D000596:Amino Acids; D007328:Insulin; D007651:Keto Acids; C013082:alpha-ketoisocaproic acid; D007930:Leucine